DevikaGovindDasMDMSHQS

Hematologic Oncology, Thoracic Cancer

Physician

Dr. Das is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Devika Das, MD, is an oncology specialist based in Gainesville, FL, with subspecialties in hematologic oncology and thoracic cancer. She completed her fellowship in hematology and medical oncology, and her residency in internal medicine at the University of Alabama Medical Center. Additionally, she holds a Master's in Healthcare Quality and Safety from UAB School of Health Professions. Dr. Das is currently an Associate Professor at the University of Florida and continues her role as an Assistant Professor at UAB Health System. She is also a Medical Director at Parexel. Her published works focus on various oncology topics, including immune checkpoint inhibitors, breast cancer treatment, and safety in oncology care delivery.

UAB School of Health Professions MSHQS, Healthcare Quality and Safety, 2018 - 2020
University of Alabama Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
University of Alabama Medical CenterResidency, Internal Medicine, 2009 - 2012
Grant Medical CollegeClass of 2007

PubMed

Risk of Knowledge Gaps Among Nononcologists Caring for Patients With Cancer: The Example of Immune Checkpoint Inhibitors.
Garrett Bourne, Devika Das, Joseph O Jacobson, Navid Sadeghi
JCO Oncology Practice. 2024-10-01
2 citations
Targeting EMT using low-dose Teniposide by downregulating ZEB2-driven activation of RNA polymerase I in breast cancer.
Brandon J Metge, Heba Allah M Alsheikh, Sarah C Kammerud, Dongquan Chen, Devika Das
Cell Death & Disease. 2024-05-08
Physician Disruptive Behavior Compromising Safe Care Delivery.
Monika Kumar, Devika Das, Therese M Mulvey, Navid Sadeghi
JCO Oncology Practice. 2024-03-01

More “Bang for the Buck?” Keys to Decision-Making in Perioperative Early-Stage NSCLCMay 5th, 2023
Should You Be “Wary of Immunotherapy” in Certain Patients With NSCLC?April 28th, 2023
Management of Lung Cancer Patients With Uncommon EGFR MutationsFebruary 27th, 2023
Join now to see all